18-23933804-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_198129.4(LAMA3):​c.8731C>T​(p.Leu2911=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 1,613,476 control chromosomes in the GnomAD database, including 32,634 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2284 hom., cov: 33)
Exomes 𝑓: 0.20 ( 30350 hom. )

Consequence

LAMA3
NM_198129.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.542
Variant links:
Genes affected
LAMA3 (HGNC:6483): (laminin subunit alpha 3) The protein encoded by this gene belongs to the laminin family of secreted molecules. Laminins are heterotrimeric molecules that consist of alpha, beta, and gamma subunits that assemble through a coiled-coil domain. Laminins are essential for formation and function of the basement membrane and have additional functions in regulating cell migration and mechanical signal transduction. This gene encodes an alpha subunit and is responsive to several epithelial-mesenchymal regulators including keratinocyte growth factor, epidermal growth factor and insulin-like growth factor. Mutations in this gene have been identified as the cause of Herlitz type junctional epidermolysis bullosa and laryngoonychocutaneous syndrome. Alternative splicing and alternative promoter usage result in multiple transcript variants. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 18-23933804-C-T is Benign according to our data. Variant chr18-23933804-C-T is described in ClinVar as [Benign]. Clinvar id is 255578.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.542 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.225 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LAMA3NM_198129.4 linkuse as main transcriptc.8731C>T p.Leu2911= synonymous_variant 67/75 ENST00000313654.14
LAMA3NM_000227.6 linkuse as main transcriptc.3904C>T p.Leu1302= synonymous_variant 30/38 ENST00000269217.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LAMA3ENST00000313654.14 linkuse as main transcriptc.8731C>T p.Leu2911= synonymous_variant 67/751 NM_198129.4 P1Q16787-2
LAMA3ENST00000269217.11 linkuse as main transcriptc.3904C>T p.Leu1302= synonymous_variant 30/381 NM_000227.6 Q16787-1

Frequencies

GnomAD3 genomes
AF:
0.156
AC:
23694
AN:
152142
Hom.:
2277
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0425
Gnomad AMI
AF:
0.0811
Gnomad AMR
AF:
0.148
Gnomad ASJ
AF:
0.144
Gnomad EAS
AF:
0.167
Gnomad SAS
AF:
0.238
Gnomad FIN
AF:
0.249
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.207
Gnomad OTH
AF:
0.149
GnomAD3 exomes
AF:
0.190
AC:
47764
AN:
251310
Hom.:
4978
AF XY:
0.194
AC XY:
26385
AN XY:
135832
show subpopulations
Gnomad AFR exome
AF:
0.0349
Gnomad AMR exome
AF:
0.174
Gnomad ASJ exome
AF:
0.139
Gnomad EAS exome
AF:
0.166
Gnomad SAS exome
AF:
0.237
Gnomad FIN exome
AF:
0.245
Gnomad NFE exome
AF:
0.203
Gnomad OTH exome
AF:
0.183
GnomAD4 exome
AF:
0.201
AC:
293494
AN:
1461216
Hom.:
30350
Cov.:
34
AF XY:
0.202
AC XY:
146768
AN XY:
726944
show subpopulations
Gnomad4 AFR exome
AF:
0.0306
Gnomad4 AMR exome
AF:
0.174
Gnomad4 ASJ exome
AF:
0.143
Gnomad4 EAS exome
AF:
0.180
Gnomad4 SAS exome
AF:
0.238
Gnomad4 FIN exome
AF:
0.238
Gnomad4 NFE exome
AF:
0.206
Gnomad4 OTH exome
AF:
0.181
GnomAD4 genome
AF:
0.156
AC:
23709
AN:
152260
Hom.:
2284
Cov.:
33
AF XY:
0.158
AC XY:
11734
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.0423
Gnomad4 AMR
AF:
0.148
Gnomad4 ASJ
AF:
0.144
Gnomad4 EAS
AF:
0.168
Gnomad4 SAS
AF:
0.237
Gnomad4 FIN
AF:
0.249
Gnomad4 NFE
AF:
0.207
Gnomad4 OTH
AF:
0.155
Alfa
AF:
0.186
Hom.:
5585
Bravo
AF:
0.140
Asia WGS
AF:
0.210
AC:
732
AN:
3478
EpiCase
AF:
0.190
EpiControl
AF:
0.186

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Laryngo-onycho-cutaneous syndrome Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Junctional epidermolysis bullosa gravis of Herlitz Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Junctional epidermolysis bullosa, non-Herlitz type Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
5.3
DANN
Benign
0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1131521; hg19: chr18-21513768; COSMIC: COSV52530854; COSMIC: COSV52530854; API